Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community

NACompletedINTERVENTIONAL
Enrollment

835

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Opioid-use DisorderHIV InfectionsTuberculosisHepatitis CHepatitis BDepressionSyphilis
Interventions
BEHAVIORAL

SBIRT

First, the BI is designed to inform potential participants on the risks of substance misuse, abuse, and dependency by illustrating the potential hazards and adverse health consequences. Second, the BI aims to motivate potential participants to reduce risky behavior (e.g., continued drug use) and seek treatment for their substance dependence disorder. In our BI, we will provide evidence-based information on Opioid Agonist Therapy (OAT) that is available to them in the community upon release or in the community. We will inform them of the risks and benefits of OAT and explain to them how OAT can be accessed in the community. OAT is provided at no cost to Ukrainian, Moldovan, and Kyrgyz citizens with opioid dependence. The BI will last approximately 20 minutes and time will be made available for them to ask questions. The BI will not be audio recorded.

Trial Locations (3)

Unknown

AIDS Foundation East-West, Bishkek

AFI - Act for Involvement, Chisinau

Ukrainian Institute for Public Health Policy, Kyiv

All Listed Sponsors
collaborator

Ukrainian Institute on Public Health Policy

OTHER

collaborator

AFEW Kyrgyzstan

UNKNOWN

collaborator

AFI - Act For Involvement

UNKNOWN

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT04947475 - Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community | Biotech Hunter | Biotech Hunter